| Tag | Content |
|---|
EnhancerAtlas ID | HS045-57027 |
Organism | Homo sapiens |
Tissue/cell | Fetal_lung |
Coordinate | chr6:14130660-14131690 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Zfx | MA0146.2 | chr6:14130715-14130729 | GAGGCCGAGGCGGG | - | 6.01 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10175 | chr6:14128443-14131653 | CD19_Primary | | SE_10872 | chr6:14127350-14132227 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr6 | 14130753 | 14130981 | | chr6 | 14131001 | 14131306 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH06I014128 | chr6 | 14128560 | 14131570 |
|
Enhancer Sequence | TTCACAGAAA GCAAGCCGCG CACGGTGGCT CACGCCTGTA ATCCCAGAAC TTTGGGAGGC 60
CGAGGCGGGC GGATCGCTTG AGTCTGGGAG TTCAAGACCA GCTTGGGCAA CAGAGCAAGA 120
CACTGCCTCT AAAAAAACAA ACAAATAAAA ATTAGCCAGG TGTGGTGGCA CAGGCTTCTA 180
GTCCTAGCTA CTGGAGAGGC TGAGGTGGGA GTACCAGAAG GTTGACTCAG GAGGCCAAGG 240
GTGCAGTGAG CCATGATCAA GCCAGTTCTC TCCAGCCTGG GTGATAGAGC GAGACCCTGT 300
CTCAAAAAAG AAAAAAAGAA AGCCAGCCAG ATAAAATGTC TGGCTAAATT GGGCATCTCC 360
CCAAGTCCGG CTGGTCTGTC CTGAGTACAG TGAAGTCAGC TGTTACTGCC CTTCCATGTG 420
GAGTTTGATA TGAGCAGCAA ATGATCTGAC ACATACACTC TCTATAAAGC ATGCTTCTCA 480
GCTGTCTCAC TGCCATAGTA CAGAGAAAAG GTGTGGCACA TTCGGCGACG TCAGGCATGA 540
CCACACAGAG ACACAGCCCT TGAGGAACAA GGTGACTGTT CGCAGGAGGC GTTGCTCATC 600
TGCTTATCTG ATTTTAGTTG AATTGTCTGG CAAGGATCAT AACAGATTTA GGAATTTTTC 660
CAAATAAAAG GCTGGGATAC AAAAATAGGA ATCATTCAGT GGGTGAGTTG GTATCTGAAG 720
AAAACAAGAG AACATTTAAT ACAGAACAGT CCTATCTATA CATGTATACA TAGACACAAA 780
ATATAATCCA GCAAGATTCA CACACAGCAT ATCACTGTCA TCAACAGTGA CTCTCTCTCC 840
CTAATATAGG GTGGAAATTG GGATACTTAT GATAGAATCA TGAGATGTAG TCCTGATATA 900
TTCCGAAGAT GTAGCCTTGG GAATTTTCAT AGATCTTTCC TCCCCCAGAG GTCACACACA 960
CACAAAAGCA TCACGTCTTG TTTTACAAAC ATAAGTTGAG GCTGGATCTT CTGAAAACAA 1020
AATGGAAACA 1030
|
